Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders
Submission Deadline: 31 Dec 2024
Guest Editors

HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Danube Neuroscience Research Laboratory, Szeged, Hungary
Interests: neurohormones; neuropeptides; tryptophan; kynurenine; psychiatry; neurology; depression; anxiety; dementia; cognition; pain; antidepressant; translational research
Special Issues in IMR Press journals
Special Issue in Probing behavioral and psychological domains in psychiatric disorders and comorbidities
Special Issue in Identifying Behavioral Patterns in Neuropsychiatry Disorders: Recent Advances in Preclinical, Clinical and Translational Research
Special Issue in Exploring Pathomechanisms, Novel Targets, and New Interventions of Neurological and Neuropsychiatric Disorders - Volume 2

Department of Psychology, University of Turin, Turin, Italy;Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Bologna, Italy
Interests: NIBS techniques; TMS; fear learning; prefrontal cortex; heart-rate variability; neuropsychology; mood disorders; stress-related disorders; psychophysiology; neurodegenerative disorders
Special Issues in IMR Press journals
Special Issue Information
Dear Colleagues,
Neurological and neuropsychiatric disorders are being studied at multiple levels. What we experience as mental illness can be studied at the psychological level, with a specific a focus on psychological symptoms, cognitive dysfunctions and affective disorders, as well as on a biological level, to elucidate molecular, cellular and brain circuit mechanisms underlying these pathological states.
Many branches of Neuroscience can help us understand the underlying biological factors and neural computations behind brain alterations and psychiatric disorders, as well as determine where and how to focus research and treatment. Currently, the great majority of neurological and neuropsychiatric diseases lack effective disease-modifying treatments, thus highlighting the urgent need for new and effective therapeutic strategies. In recent years, non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial electric current stimulation (TES), have been developed. These techniques are currently being investigated in patients experiencing both neurological and neuropsychiatric disorders for diagnostic and therapeutic purposes.
This Special Issue highlights the most recent advances in experimental, clinical, and translational research in the fields of neurology and neuropsychiatry, focusing on neural correlates in the development of cognitive impairment and emotional disturbance. We invite authors to contribute original research articles focusing on (but not limited to) the following:
• Etiology, pathogenesis and progression mechanisms;
• Early diagnosis including biomarkers, bio-imaging, and biosensors;
• Prophylactic, disease-modifying and therapeutic strategies;
• Novel drug discovery and development, naturally driven biomedicines, natural bioactive molecules and vaccines;
• Preclinical in vitro and animal models;
• Bench-to-bedside translational research;
• Bedside-to-bench translational research;
• Non-invasive brain stimulation (NIBS) for diagnosis and treatment of neuropsychiatric disorders.
Comprehensive reviews, systematic reviews, and meta-analysis articles are also welcome.
Dr. Masaru Tanaka and Dr. Simone Battaglia
Guest Editors
Keywords
- neurological diseases
- psychiatric disorders
- non-invasive brain stimulation
- altered cognitive processes
- neurocognitive disorders
- neurodegenerative disorders
- cognitive, behavioral, and functional disorders
Published Papers (11)
mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy
Front. Biosci. (Landmark Ed) 2025, 30(8), 26637; https://doi.org/10.31083/FBL26637
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Acquired Piezo2 Channelopathy is One Principal Gateway to Pathophysiology
Front. Biosci. (Landmark Ed) 2025, 30(5), 33389; https://doi.org/10.31083/FBL33389
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Novel Plasma Biomarkers for Alzheimer’s Disease: Insights from Organotypic Brain Slice and Microcontact Printing Techniques
Front. Biosci. (Landmark Ed) 2025, 30(3), 36257; https://doi.org/10.31083/FBL36257
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Dexmedetomidine Protects the Brain: Exploring the α2AR/FAK Pathway in Post-Stroke Intestinal Barrier Repair
Front. Biosci. (Landmark Ed) 2025, 30(2), 27159; https://doi.org/10.31083/FBL27159
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models
Front. Biosci. (Landmark Ed) 2025, 30(2), 26679; https://doi.org/10.31083/FBL26679
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder
Front. Biosci. (Landmark Ed) 2025, 30(1), 25706; https://doi.org/10.31083/FBL25706
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity
Front. Biosci. (Landmark Ed) 2023, 28(12), 355; https://doi.org/10.31083/j.fbl2812355
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Microglia and Stem Cells for Ischemic Stroke Treatment—Mechanisms, Current Status, and Therapeutic Challenges
Front. Biosci. (Landmark Ed) 2023, 28(10), 269; https://doi.org/10.31083/j.fbl2810269
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
From Mechanisms to Implications: Understanding the Molecular Neurotoxicity of Titanium Dioxide Nanoparticles
Front. Biosci. (Landmark Ed) 2023, 28(9), 204; https://doi.org/10.31083/j.fbl2809204
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies
Front. Biosci. (Landmark Ed) 2023, 28(8), 171; https://doi.org/10.31083/j.fbl2808171
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
Lycium barbarum Ameliorates Neural Damage Induced by Experimental Ischemic Stroke and Radiation Exposure
Front. Biosci. (Landmark Ed) 2023, 28(2), 38; https://doi.org/10.31083/j.fbl2802038
(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions for Neurological and Neuropsychiatric Disorders)
